Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 07-2025 | 04-2025 | 01-2025 | 10-2024 | 07-2024 | |
| Operating Expenses | 848 | 1,043 | 960 | 1,106 | 1,269 |
| Operating Income | -848 | -1,043 | -960 | -1,106 | -1,269 |
| Other Income | -7,512 | 12,792 | -2,085 | -364 | 24,690 |
| Pre-tax Income | -8,360 | 11,750 | -3,045 | -1,470 | 23,421 |
| Net Income Continuous | -8,360 | 11,750 | -3,045 | -1,470 | 23,421 |
| Net Income | $-8,360 | $11,750 | $-3,045 | $-1,470 | $23,421 |
| EPS Basic Total Ops | -1.23 | 2.12 | -0.44 | -0.39 | 1.90 |
| EPS Basic Continuous Ops | -1.23 | 1.84 | -0.44 | -0.19 | 2.98 |
| EPS Diluted Total Ops | -1.23 | 2.12 | -0.44 | -0.39 | 1.90 |
| EPS Diluted Continuous Ops | -1.23 | 1.84 | -0.44 | -0.19 | 2.98 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.25 | -0.10 | -0.29 | 0.14 |
| EBITDA(a) | $-848 | $-1,043 | $-960 | $-1,106 | $-1,269 |